Ikapharmindo Putramas Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Sarimelati Kencana Tbk. trades at Rp185 (market cap 553B, 3.72M 24h volume). The key difference: Sarimelati Kencana Tbk. is the larger of the two by market cap, and Sarimelati Kencana Tbk. is more actively traded (3.72M versus 13.7K). Which is the better fit depends on your goals.
| IKPM | PZZA | |
|---|---|---|
Market Cap | 304.92B | 553B |
Volume | 13.7K | 3.72M |
Lot | 137 | 37.22K |
Turnover | 2.49M | 666.16M |
Average Price | 181.39 | 179 |
Value | 2.49M | 666.16M |
Indicative Equilibrium Price | — | 185 |
Indicative Equilibrium Volume | — | 50 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Read more on PZZA →